Archeon Medical

Key People

• Alban De Luca - President, CEO & Founder
• Pierre-Edouard Saillard - COO & Co-Founder
• Christian Martin - Board Member
• Lourens Verweij - Board Member

Assessment

Team

Aspect: First-time 10+ yrs
Summary: The founding team comprises first-time entrepreneurs with over a decade of experience in the medical technology sector.

Alban De Luca and Pierre-Edouard Saillard, the founders of Archeon Medical, have over ten years of experience in the medical technology industry. Their deep understanding of the sector's challenges and opportunities enhances the company's potential for success.

Clinical Need

Aspect: Very Strong
Summary: EOlife addresses a critical need in emergency medical care by improving manual ventilation practices.

Manual ventilation is a vital component of emergency medical care, yet it is often performed suboptimally. EOlife provides real-time feedback on tidal volume and ventilation frequency, ensuring adherence to guidelines and improving patient outcomes during cardiopulmonary resuscitation (CPR).

Competition

Aspect: First mover
Summary: Archeon Medical is a pioneer in the field of manual ventilation feedback devices.

EOlife is among the first devices to offer real-time feedback on manual ventilation, addressing a previously unmet need in emergency medical care. This pioneering position allows Archeon Medical to set industry standards and build strong brand recognition.

Technical Challenge

Aspect: Predictable
Summary: The development of EOlife involves predictable technical challenges within the MedTech field.

Developing a device like EOlife requires integrating sensors and software to provide accurate real-time feedback. While this involves technical complexity, it falls within the predictable challenges faced in medical device development, making it manageable for an experienced team.

Patent

Aspect: Very Strong
Summary: EOlife is protected by strong patents, providing a significant competitive advantage.

Archeon Medical holds patents for EOlife's unique technology, which calculates the exact amount of air/oxygen delivered to a patient's lungs. This intellectual property protection prevents competitors from replicating the technology, ensuring a strong market position.

Financing

Aspect: Well-funded
Summary: Archeon Medical has secured substantial funding to support its growth and expansion.

In June 2024, Archeon Medical closed a multi-million-euro funding round led by Bpifrance and several private banking funds. This investment enables the company to accelerate international expansion and further develop its product offerings.

Regulatory

Aspect: 510k/PMA
Summary: EOlife has obtained FDA clearance, facilitating its entry into the U.S. market.

In 2023, EOlife received FDA clearance, allowing Archeon Medical to market the device in the United States. This regulatory milestone is crucial for expanding the company's presence in a key market and demonstrates compliance with stringent medical device standards.

Opportunity Rollup

Odds of Success

3.8

Peak Market Share

5.25

Segment CAGR

3.4%

Market Segment

Anesthesia and Respiratory Devices

Market Sub Segment

Ventilation Feedback Devices

Key Takeaway

Archeon Medical's innovative EOlife device addresses a critical need in emergency medical care, supported by a strong team, robust patents, and substantial funding, positioning the company for significant growth in the global healthcare market.